Cita APA (7a ed.)

Şahin, A. B., Cubukcu, E., Ocak, B., Deligonul, A., Orhan, S. O., Tolunay, S., . . . Evrensel, T. (2021). Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. Nature Portfolio.

Cita Chicago Style (17a ed.)

Şahin, Ahmet Bilgehan, et al. Low Pan-immune-inflammation-value Predicts Better Chemotherapy Response and Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Şahin, Ahmet Bilgehan, et al. Low Pan-immune-inflammation-value Predicts Better Chemotherapy Response and Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Nature Portfolio, 2021.